Skip to main content

Table 1 Baseline pathological and clinical characteristics of patients

From: Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection

 

No. (%)

Age, median, years

54 (43–63)

 ≤65

84 (84.0%)

 > 65

16 (16.0%)

Sex

 Male

73 (73.0%)

 Female

27 (27.0%)

KPS

 90

78 (78.0%)

 80

22 (22.0%)

BMI, median,

21.4 (19.5–23.6)

Primary tumor length, median, cm

7.4 (1.7–8.9)

Primary tumor location

 Sigmoid colon

60 (60.0%)

 Descending colon

3 (3.0%)

 Transverse colon

10 (10.0%)

 Ascending colon

25 (25.0%)

 Ileocecus

2 (2.0%)

Tumor differentiation

 High

20 (20.0%)

 Moderate

65 (65.0%)

 Low

15 (15.0%)

CEA pre-CRT, median, ng/ml

6.1 (3.0–21.3)

Complication

 No

56 (56.0%)

 Yes

44 (44.0%)

cT stage

 T3

4 (4.0%)

 T4a

12 (12.0%)

 T4b

84 (84.0%)

cN stage

 N0

1 (1.0%)

 N1

36 (36.0%)

 N2

63 (63.0%)

Clinical stage

 IIC

1 (1.0%)

 IIIB

16 (16.0%)

 IIIC

83 (83.0%)

Involved organ

 Bladder

42 (42.0%)

 Ureter

12 (12.0%)

 Renal and perirenal fat, prerenal space

6 (6.0%)

 Pelvic wall

10 (10.0%)

 Presacral space

2 (2.0%)

 Abdominal wall

11 (11.0%)

 Mesentery

2 (2.0%)

 Great vessel

8 (8.0%)

 Small intestine

26 (26.0%)

 Greater omentum

5 (5.0%)

 Gallbladder

6 (6.0%)

 Liver

9 (9.0%)

 Appendix

1 (1.0%)

 Pancreas

2 (2.0%)

 Uterus

6 (6.0%)

 Vagina

1 (1.0%)

 Seminal vesicle gland

3 (3.0%)

 Vas deferens

2 (2.0%)

 Iliopsoas muscle

1 (1.0%)

Bladder fistula/perforation

 Yes

14 (14.0%)

 No

86 (86.0%)

Intestinal obstruction

 Yes

19 (19.0%)

 No

81 (81.0%)

Family history

 Yes

20 (20.0%)

 No

80 (80.0%)

Charlson Comorbidity Score

 0

82 (82.0%)

 1

15 (15.0%)

 2

2 (2.0%)

 3

1 (1.0%)

MMR

 dMMR

14 (22.6%)

 pMMR

48 (77.4%)

 Unknown

38

  1. Abbreviations: KPS Karnofsky Performance Status, BMI Body Mass Index, cT stage Clinical T stage, cN stage Clinical N stage, MMR Mismatch repair phenotype